世界の水痘帯状疱疹ウイルス（VZV）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Varicella-Zoster Virus (VZV) Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5863
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、水痘帯状疱疹ウイルス（VZV）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アシクロビル、バラシクロビル、ファムシクロビル、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・水痘帯状疱疹ウイルス（VZV）治療の市場動向
・企業の競争状況、市場シェア
・水痘帯状疱疹ウイルス（VZV）治療の種類別市場規模（アシクロビル、バラシクロビル、ファムシクロビル、その他）
・水痘帯状疱疹ウイルス（VZV）治療の用途別市場規模（病院薬局、小売薬局、オンライン薬局）
・水痘帯状疱疹ウイルス（VZV）治療の北米市場規模2016-2027（アメリカ、カナダ）
・水痘帯状疱疹ウイルス（VZV）治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・水痘帯状疱疹ウイルス（VZV）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・水痘帯状疱疹ウイルス（VZV）治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・水痘帯状疱疹ウイルス（VZV）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Roche、Merck、Pfizer、Novartis、Abbott、GlaxoSmithKline、Sanofi、Eli Lilly、Astrazeneca、Johnson & Johnson）
・結論

Market Analysis and Insights: Global Varicella-Zoster Virus (VZV) Treatment Market
The global Varicella-Zoster Virus (VZV) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Varicella-Zoster Virus (VZV) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Varicella-Zoster Virus (VZV) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Varicella-Zoster Virus (VZV) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Varicella-Zoster Virus (VZV) Treatment market.

Global Varicella-Zoster Virus (VZV) Treatment Scope and Market Size
Varicella-Zoster Virus (VZV) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Varicella-Zoster Virus (VZV) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Acyclovir
Valacyclovir
Famciclovir
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Sanofi
Eli Lilly
Astrazeneca

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Varicella-Zoster Virus (VZV) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Acyclovir
1.2.3 Valacyclovir
1.2.4 Famciclovir
1.2.5 Others
1.3 Market by Application
1.3.1 Global Varicella-Zoster Virus (VZV) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Varicella-Zoster Virus (VZV) Treatment Market Perspective (2016-2027)
2.2 Varicella-Zoster Virus (VZV) Treatment Growth Trends by Regions
2.2.1 Varicella-Zoster Virus (VZV) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Varicella-Zoster Virus (VZV) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Varicella-Zoster Virus (VZV) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Varicella-Zoster Virus (VZV) Treatment Industry Dynamic
2.3.1 Varicella-Zoster Virus (VZV) Treatment Market Trends
2.3.2 Varicella-Zoster Virus (VZV) Treatment Market Drivers
2.3.3 Varicella-Zoster Virus (VZV) Treatment Market Challenges
2.3.4 Varicella-Zoster Virus (VZV) Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Varicella-Zoster Virus (VZV) Treatment Players by Revenue
3.1.1 Global Top Varicella-Zoster Virus (VZV) Treatment Players by Revenue (2016-2021)
3.1.2 Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Varicella-Zoster Virus (VZV) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Varicella-Zoster Virus (VZV) Treatment Revenue
3.4 Global Varicella-Zoster Virus (VZV) Treatment Market Concentration Ratio
3.4.1 Global Varicella-Zoster Virus (VZV) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Varicella-Zoster Virus (VZV) Treatment Revenue in 2020
3.5 Varicella-Zoster Virus (VZV) Treatment Key Players Head office and Area Served
3.6 Key Players Varicella-Zoster Virus (VZV) Treatment Product Solution and Service
3.7 Date of Enter into Varicella-Zoster Virus (VZV) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Varicella-Zoster Virus (VZV) Treatment Breakdown Data by Type
4.1 Global Varicella-Zoster Virus (VZV) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Varicella-Zoster Virus (VZV) Treatment Forecasted Market Size by Type (2022-2027)

5 Varicella-Zoster Virus (VZV) Treatment Breakdown Data by Application
5.1 Global Varicella-Zoster Virus (VZV) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Varicella-Zoster Virus (VZV) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Varicella-Zoster Virus (VZV) Treatment Market Size (2016-2027)
6.2 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Type
6.2.1 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021)
6.2.2 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027)
6.2.3 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2027)
6.3 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Application
6.3.1 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021)
6.3.2 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027)
6.3.3 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2027)
6.4 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Country
6.4.1 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021)
6.4.2 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Varicella-Zoster Virus (VZV) Treatment Market Size (2016-2027)
7.2 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Type
7.2.1 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2027)
7.3 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Application
7.3.1 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2027)
7.4 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Country
7.4.1 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Type
8.2.1 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Application
8.3.1 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Region
8.4.1 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size (2016-2027)
9.2 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Type
9.2.1 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2027)
9.3 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Application
9.3.1 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2027)
9.4 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Country
9.4.1 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Type
10.2.1 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Application
10.3.1 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Country
10.4.1 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Varicella-Zoster Virus (VZV) Treatment Introduction
11.1.4 Roche Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Varicella-Zoster Virus (VZV) Treatment Introduction
11.2.4 Merck Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Varicella-Zoster Virus (VZV) Treatment Introduction
11.3.4 Pfizer Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Varicella-Zoster Virus (VZV) Treatment Introduction
11.4.4 Novartis Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Varicella-Zoster Virus (VZV) Treatment Introduction
11.5.4 Abbott Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
11.5.5 Abbott Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Varicella-Zoster Virus (VZV) Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Varicella-Zoster Virus (VZV) Treatment Introduction
11.7.4 Sanofi Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Varicella-Zoster Virus (VZV) Treatment Introduction
11.8.4 Eli Lilly Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
11.8.5 Eli Lilly Recent Development
11.9 Astrazeneca
11.9.1 Astrazeneca Company Details
11.9.2 Astrazeneca Business Overview
11.9.3 Astrazeneca Varicella-Zoster Virus (VZV) Treatment Introduction
11.9.4 Astrazeneca Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
11.9.5 Astrazeneca Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Varicella-Zoster Virus (VZV) Treatment Introduction
11.10.4 Johnson & Johnson Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Varicella-Zoster Virus (VZV) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Acyclovir
Table 3. Key Players of Valacyclovir
Table 4. Key Players of Famciclovir
Table 5. Key Players of Others
Table 6. Global Varicella-Zoster Virus (VZV) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Varicella-Zoster Virus (VZV) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Varicella-Zoster Virus (VZV) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Regions (2016-2021)
Table 10. Global Varicella-Zoster Virus (VZV) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Regions (2022-2027)
Table 12. Varicella-Zoster Virus (VZV) Treatment Market Trends
Table 13. Varicella-Zoster Virus (VZV) Treatment Market Drivers
Table 14. Varicella-Zoster Virus (VZV) Treatment Market Challenges
Table 15. Varicella-Zoster Virus (VZV) Treatment Market Restraints
Table 16. Global Varicella-Zoster Virus (VZV) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Players (2016-2021)
Table 18. Global Top Varicella-Zoster Virus (VZV) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Varicella-Zoster Virus (VZV) Treatment as of 2020)
Table 19. Ranking of Global Top Varicella-Zoster Virus (VZV) Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Varicella-Zoster Virus (VZV) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Varicella-Zoster Virus (VZV) Treatment Product Solution and Service
Table 23. Date of Enter into Varicella-Zoster Virus (VZV) Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Varicella-Zoster Virus (VZV) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Varicella-Zoster Virus (VZV) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Varicella-Zoster Virus (VZV) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Varicella-Zoster Virus (VZV) Treatment Product
Table 66. Roche Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Merck Company Details
Table 69. Merck Business Overview
Table 70. Merck Varicella-Zoster Virus (VZV) Treatment Product
Table 71. Merck Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million)
Table 72. Merck Recent Development
Table 73. Pfizer Company Details
Table 74. Pfizer Business Overview
Table 75. Pfizer Varicella-Zoster Virus (VZV) Treatment Product
Table 76. Pfizer Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million)
Table 77. Pfizer Recent Development
Table 78. Novartis Company Details
Table 79. Novartis Business Overview
Table 80. Novartis Varicella-Zoster Virus (VZV) Treatment Product
Table 81. Novartis Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million)
Table 82. Novartis Recent Development
Table 83. Abbott Company Details
Table 84. Abbott Business Overview
Table 85. Abbott Varicella-Zoster Virus (VZV) Treatment Product
Table 86. Abbott Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million)
Table 87. Abbott Recent Development
Table 88. GlaxoSmithKline Company Details
Table 89. GlaxoSmithKline Business Overview
Table 90. GlaxoSmithKline Varicella-Zoster Virus (VZV) Treatment Product
Table 91. GlaxoSmithKline Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million)
Table 92. GlaxoSmithKline Recent Development
Table 93. Sanofi Company Details
Table 94. Sanofi Business Overview
Table 95. Sanofi Varicella-Zoster Virus (VZV) Treatment Product
Table 96. Sanofi Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million)
Table 97. Sanofi Recent Development
Table 98. Eli Lilly Company Details
Table 99. Eli Lilly Business Overview
Table 100. Eli Lilly Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million)
Table 101. Eli Lilly Recent Development
Table 102. Astrazeneca Company Details
Table 103. Astrazeneca Business Overview
Table 104. Astrazeneca Varicella-Zoster Virus (VZV) Treatment Product
Table 105. Astrazeneca Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million)
Table 106. Astrazeneca Recent Development
Table 107. Johnson & Johnson Company Details
Table 108. Johnson & Johnson Business Overview
Table 109. Johnson & Johnson Varicella-Zoster Virus (VZV) Treatment Product
Table 110. Johnson & Johnson Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million)
Table 111. Johnson & Johnson Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Type: 2020 VS 2027
Figure 2. Acyclovir Features
Figure 3. Valacyclovir Features
Figure 4. Famciclovir Features
Figure 5. Others Features
Figure 6. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Varicella-Zoster Virus (VZV) Treatment Report Years Considered
Figure 11. Global Varicella-Zoster Virus (VZV) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Varicella-Zoster Virus (VZV) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Regions (2022-2027)
Figure 15. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Players in 2020
Figure 16. Global Top Varicella-Zoster Virus (VZV) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Varicella-Zoster Virus (VZV) Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Varicella-Zoster Virus (VZV) Treatment Revenue in 2020
Figure 18. Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Varicella-Zoster Virus (VZV) Treatment Market Share by Type (2016-2027)
Figure 22. North America Varicella-Zoster Virus (VZV) Treatment Market Share by Application (2016-2027)
Figure 23. North America Varicella-Zoster Virus (VZV) Treatment Market Share by Country (2016-2027)
Figure 24. United States Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Varicella-Zoster Virus (VZV) Treatment Market Share by Type (2016-2027)
Figure 28. Europe Varicella-Zoster Virus (VZV) Treatment Market Share by Application (2016-2027)
Figure 29. Europe Varicella-Zoster Virus (VZV) Treatment Market Share by Country (2016-2027)
Figure 30. Germany Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Share by Region (2016-2027)
Figure 40. China Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Varicella-Zoster Virus (VZV) Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Varicella-Zoster Virus (VZV) Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Varicella-Zoster Virus (VZV) Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Roche Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
Figure 60. Merck Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
Figure 63. Abbott Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
Figure 65. Sanofi Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
Figure 66. Eli Lilly Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
Figure 67. Astrazeneca Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
Figure 68. Johnson & Johnson Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

以下、関連資料のご紹介

世界の帯状疱疹感染症治療市場規模・現状・予測（2021年-2027年）

Global Herpes Zoster Infection Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2813 2021年4月 98Pages
QYResearch社発行の本調査資料では、帯状疱疹感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、局所、非経口）、用途別市場規模（クリニック、病院、診断センター、在宅ケア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の眼部帯状ヘルペス治療薬市場規模・現状・予測（2021年-2027年）

Global Herpes Zoster Ophthalmicus Drug Market Size, Status and Forecast 2021-2027
QYR2104Z2814 2021年4月 92Pages
QYResearch社発行の本調査資料では、眼部帯状ヘルペス治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、外用薬、注射薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年）

Global Acute Intermittent Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0060 2021年4月 92Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界の単純ヘルペスウイルス感染症治療市場規模・現状・予測（2021年-2027年）

Global Herpes Simplex Virus Infection Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2811 2021年4月 130Pages
QYResearch社発行の本調査資料では、単純ヘルペスウイルス感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（単純ヘルペスウイルス-1（HSV-1）感染、単純ヘルペスウイルス-2（HSV-2）感染、HSV1・HSV2同時感染）、用途...

世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0096 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界の神経性食欲不振症（AN）治療市場規模・現状・予測（2021年-2027年）

Global Anorexia Nervosa Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0355 2021年4月 94Pages
QYResearch社発行の本調査資料では、神経性食欲不振症（AN）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（心理療法、薬理療法、その他）、用途別市場規模（病院、クリニック、在宅医療、その他）、主要地域別市場規模（北米、アメリカ、ヨー...

世界の神経精神障害＆治療市場規模・現状・予測（2021年-2027年）

Global Neuropsychiatric Disorders and Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4097 2021年4月 97Pages
QYResearch社発行の本調査資料では、神経精神障害＆治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、ショック治療、その他）、用途別市場規模（病院、診療所、研究センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界の顕微鏡的多発血管炎（MPA）治療市場規模・現状・予測（2021年-2027年）

Global Microscopic Polyangiitis (MPA) Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3776 2021年4月 98Pages
QYResearch社発行の本調査資料では、顕微鏡的多発血管炎（MPA）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アバコパン、免疫グロブリン、リツキシマブバイオシミラー、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別...

世界の髄膜炎診断・治療市場規模・現状・予測（2021年-2027年）

Global Meningitis Diagnosis and Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3698 2021年4月 95Pages
QYResearch社発行の本調査資料では、髄膜炎診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ウイルス性髄膜炎、細菌性髄膜炎、その他）、用途別市場規模（病院・クリニック、診断センター）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の経口血糖降下薬（OAD）治療市場規模・現状・予測（2021年-2027年）

Global Oral Antidiabetic (OAD) Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4299 2021年4月 92Pages
QYResearch社発行の本調査資料では、経口血糖降下薬（OAD）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（スルホニル尿素剤、ビグアニド、腸内α-グルコシダーゼ阻害剤、その他）、用途別市場規模（病院、診療所、糖尿病治療センター、その...

世界の帯状疱疹感染症治療市場規模・現状・予測（2021年-2027年） Herpes Zoster (shingles) is a cutaneous, acute viral infection caused by the varicella-zoster virus. Herpes Zoster is the outbreak of rash on the skin that cause burning and pain. Herpes Zoster is caused by the same virus which cause chickenpox. The virus may live in your nervous system for many yea…
世界の眼部帯状ヘルペス治療薬市場規模・現状・予測（2021年-2027年） Herpes Zoster Ophthalmicus is a diseases which activates itself due to the reoccurrence of varicella zoster virus infection. The disease involves eye and damages the eye and its surrounding structures due to inflammation of nerves. Market Analysis and Insights: Global Herpes Zoster Ophthalmicus Drug…
世界の単純ヘルペスウイルス感染症治療市場規模・現状・予測（2021年-2027年） Herpes Simplex Virus Infection is commonly known as herpes. The two types of herpes simplex virus (HSV) are HSV-1 (known to cause orofacial disease such as cold sores) and HSV-2 (causes genital infections). Over 80% of herpes infections is asymptomatic. Symptomatic infections are presented with blis…
世界の呼吸器ウイルス感染症治療薬市場規模・現状・予測（2021年-2027年） North America dominated the global respiratory virus infection drugs market in 2019. The trend is anticipated to continue during the forecast period. Strategies adopted by key players, such as product approvals & launch and mergers & acquisitions, well-established healthcare infrastructure, and earl…
世界のクッシング病治療市場規模・現状・予測（2021年-2027年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…